PHVS: Nilai perusahaan marang bathi resik Pharvaris NV
Pharvaris N.V. (PHVS) develops oral treatments for hereditary angioedema with a valuable pipeline. The company's P/E ratio objectively reflects the asset's investment attractiveness, with the indicator currently standing at -11.70. The transition to tablet forms simplifies logistics and scales the customer base. However, high R&D costs coupled with a revenue deficit are leading to the depletion of reserves and a search for external capital.
%20Pangali%20P%2FE&width=1200&height=400&colorIndex=0&v=mwg3sw3k.w4s-7di3ke8&start=20220704&end=20261114&filename=GURU_Markets_-_PHVS_-_Pharvaris-N.V._-_PE-Multiple "PHVS: Periode bali modal bisnis Pharvaris N.V. 04.07.2022 - 14.11.2026 | 👁️GURU.Markets👁️")
Rincian analitis perusahaan Pharvaris Pharma (PHVS)
- rega lan prakiraan konsensus rega:
- informasi kapitalisasi pasar:
- indikator nilai aset resik miturut neraca:
- informasi babagan utang lan solvabilitas:
Rasio Total Utang marang Ekuitas Pharvaris N.V.|PHVS - Rasio utang jangka dawa marang ekuitas|Utang jangka cendhak marang modal pharvaris.com|PHVS - Utang perusahaan|Rasio utang marang nilai buku Pharvaris NV|PHVS - Utang jangka dawa perusahaan|Utang jangka cendhak Pharvaris|Rasio likuiditas kritis pharvaris.com
- rincian bathi lan kelipatan pasar:
PHVS - Bathi resik|Penghasilan resik sing dikarepake Pharvaris N.V.|PHVS - Pangali P/E|Pangali Forward P/E Pharvaris Pharma|PHVS - Rasio rega marang bathi tumrap wutah|Nilai bisnis marang bathi operasional sadurunge panyusutan Pharvaris Pharma|PHVS - Bathi operasional sadurunge ngurangi amortisasi|Bathi saben saham sajrone rolas wulan pungkasan Pharvaris|PHVS - Bathi resik saben saham (EPS TTM)|Wutah bathi EPS kuartalan pharvaris.com|PHVS - Wutah bathi saben saham ing taun lumaku|Dinamika bathi saben saham sing diarepake ing taun ngarep Pharvaris N.V.
- indikator volume dodolan lan pendapatan:
Analisis komprehensif perusahaan:Pharvaris PHVS
The transparency of clinical roadmaps and the high scientific expertise of Pharvaris N.V. management allow investors to assess the value of each unit of profit via the company's current P/E on the GURU.Markets platform. The value of -11.70 reflects market expectations for the business capitalization, where low multiples may signal either undervaluation or systemic risks within the biotechnology sector.
Pesaing wigati
Pangali P/E Argenx|Koefisien rega marang bathi BNTX (BioNTech Group)|ABVX (abivax.com) - Nilai perusahaan marang bathi resik|Pangali P/E ADMA (admabiologics.com)|Periode bali modal bisnis protagonist-inc.com (PTGX)|IMVT - Rasio rega marang bathi|Kiniksa Pharmaceuticals, Ltd. (KNSA) - Koefisien rega marang bathi|Grifols Biemat (GRFS) - Rasio rega marang bathi|Koefisien rega marang bathi Adaptive Biotechnologies|Koefisien rega marang bathi CLDX|Pangali P/E auriniapharma.com|Rasio rega marang bathi BioCryst Pharmaceuticals Inc (BCRX)|Vera Therapeutics - Pangali rega marang bathi|Pangali P/E DNTH (dianthustx.com)|AbCellera Bio (ABCL) - Kapitalisasi marang bathi|TRML: Koefisien rega marang bathi|Kapitalisasi marang bathi resik PGEN|PHAR: Pangali P/E|Kapitalisasi marang bathi Nektar Therapeutics Inc (NKTR)|Koefisien rega marang bathi UPB|Pangali rega marang bathi ZBIO (Zenas Biopharma, Inc.)|Koefisien rega marang bathi IMNM (Immunome Bio)|Periode bali modal bisnis Gossamer Bio, Inc.|Pangali P/E KALV (KalVista Pharma)|Septerna, Inc. (SEPN) - Kapitalisasi marang bathi|PVLA - Rasio rega marang bathi|SVRA - Pangali P/E|Rigel Pharmaceuticals Inc (RIGL) - Rasio rega marang bathi|ANAB - Periode bali modal bisnis|Koefisien rega marang bathi ATXS|ENGN: Nilai perusahaan marang bathi resik|Rasio rega marang bathi RAPT Therapeutics (RAPT)|JBIO (Aerovate) - Nilai perusahaan marang bathi resik|Pangali P/E ACRS (Aclaris Therapeutics)|Nilai perusahaan marang bathi resik KYTX|Tiziana Life Sciences - Pangali P/E|CABA: Rasio rega marang bathi|VTYX: Pangali P/E|THTX (Theratechnologies, Inc) - Rasio rega marang bathi|AVTX (Avalo Therapeutics, Inc.) - Pangali P/E|Pangali P/E Eledon Pharmaceuticals|Rasio rega marang bathi Agenus Inc. (AGEN)|Koefisien rega marang bathi Climb Bio Inc. CLYM|Pangali P/E ZURA (Zura Bio Ltd)|ATYR - Koefisien rega marang bathi|ADAG - Rasio rega marang bathi|IMA - Pangali P/E|STTK: Pangali P/E|Equillium Bio (EQ) - Pangali P/E|CNTB (connectbiopharm.com) - Pangali P/E|IMUX: Nilai perusahaan marang bathi resik|Pangali P/E ATRA|Pangali P/E InflaRx NV (IFRX)|X4 Pharmaceuticals, Inc. (XFOR) - Kapitalisasi marang bathi resik|Pangali P/E adicetbio.com ACET|Celularity - Pangali P/E|Nilai perusahaan marang bathi resik INMB (INmune Bio Corp)|BRNS (Barinthus Bio) - Koefisien rega marang bathi|Kapitalisasi marang bathi resik KZR (Kezar Life Sciences)|Rasio rega marang bathi SAB Biotherapeutics Inc.|Akari Therapeutics Plc - Kapitalisasi marang bathi resik|Koefisien rega marang bathi ENLV (Enlivex Therapeutics Ltd.)|Koefisien rega marang bathi Q32 Bio Inc QTTB|Rasio rega marang bathi geovax.com GOVX|Pangali P/E edesabiotech.com EDSA|iBio Corporation - Pangali P/E|Nilai perusahaan marang bathi resik CARM (carismatx.com)|XTL Biopharmaceuticals Ltd. (XTLB) - Rasio rega marang bathi|Bolt Bio (BOLT) - Pangali P/E|HCWB (HCW Biologics Inc) - Pangali P/E|Koefisien rega marang bathi Aptevo Therapeutics (APVO)|Pangali P/E AIM|Rasio rega pasar marang bathi resik ADTX|Pangali P/E GRI (GRI Bio Corporation)|Pangali P/E XORTX Corp XRTX|HIND - Rasio rega marang bathi|Revelation Biosciences (REVB) - Koefisien rega marang bathi|INDP (Indaptus Therapeutics, Inc.) - Koefisien rega marang bathi|Scinai Immunotherapeutics Ltd (SCNI) - Pangali P/E|CALI (CalciMedica Inc) - Pangali P/E|affimed.com - Kapitalisasi marang bathi resik|Rasio rega marang bathi allakos.com (ALLK)|Pangali P/E HOOKIPA Pharma, Inc. (HOOK)|IGM Biosciences Inc. - Koefisien rega marang bathi|iTeos Therapeutics, Inc. (ITOS) - Kapitalisasi marang bathi|OCEA: Koefisien rega marang bathi|Nilai perusahaan marang bathi resik TCBP (TC BioPharm (Holdings) PLC)|THRD: Pangali P/E
